Emerging Markets to Play a Key Role in the Pharmaceutical Industry's Growth

Online, September 1, 2012 (Newswire.com) - IMARC Group, one of the world's leading research and advisory firms, expects the emerging markets to play a key role in driving the growth of the pharmaceutical industry. With growth in the more developed markets such as the US, Europe and Japan already stagnated, it is the consumers in countries like China, India, Brazil, Russia, Mexico and Turkey that are expected to provide the thrust for future growth. Factors such as a large population, rising incomes and expanding healthcare infrastructure are expected to allow more people in the emerging markets to afford western medication. Although per capita drug spending in these markets remains far lower than those in the developed markets, the sheer size of the population in these regions is expected to create a major impact on the global market growth.

IMARC Group, one of the world's leading research and advisory firms, introduces a new and revolutionary way to understand and evaluate the global pharmaceutical market with its Microsoft Excel based report entitled "Global Pharmaceutical Market Report & Forecast: 2012-2017". IMARC group estimates that the global pharmaceutical market is expected to grow at a CAGR of 6% during 2011-2017, exceeding sales worth US$ 1.1 Trillion by 2017. This market, however, is expected to undergo a number of transitions which would impact the course of this growth. As a result of these transformations; the need for a user friendly, robust and comprehensive pharmaceutical market intelligence has become imperative for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the pharmaceutical market in some form or the other.

This report provides an analytical and statistical insight into the global pharmaceutical market. The study which has been undertaken using both desk research as well as qualitative primary research has analyzed the following aspects of the global pharmaceutical market.

What We Have Achieved in This Report?

Regions Covered: Global, North America, Asia Pacific, Latin America & Caribbean and Middle East & Africa

Countries Covered in Each Region:

North America: United States and Canada

Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherland, Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania, Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia, Slovenia, Lithuania, Latvia, Luxembourg and Estonia

Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and Singapore

Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico, Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay

Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab Emirates Lebanon, Tunisia, Jordan, Kuwait

Focus of the Analysis:
• Historical Sales Performance (2007-2011) for Each Country
• Historical Sales Performance (2007-2011) for Each Region
• Sales Forecast (2012-2017) for Each Country
• Sales Forecast (2012-2017) for Each Region
• Sales Performance of Key Manufacturers for Each Country (2007-2011)
• Sales Performance of Key Therapeutic Areas for Each Country (2007-2011)
• Country Wise Sales Breakup for Each Region (2007-2011)
• Country Wise Sales Breakup Forecast for Each Region (2012-2017)

To buy the complete report or to get a free sample, please contact:
IMARC Group - Asia
Email: [email protected]
Phone: +91-120-415-5099
IMARC Group - Europe, Middle East & Africa
Email: [email protected]
Phone: +44-702-409-7331
IMARC Group - Europe, Middle East & Africa
Email: [email protected]
Phone: +1-631-791-1145

For More Information please Visit: http://www.imarcgroup.com/global-pharmaceutical-market-report-forecast-2012-2017/